Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enveric Biosciences Inc (NQ: ENVB ) 0.4710 -0.0080 (-1.67%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Enveric Biosciences Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > Why Is Enveric Biosciences (ENVB) Stock Up 120% Today? May 18, 2023 Enveric Biosciences’ Notice of Allowance for a therapeutic patent is bolstering ENVB stock, but investors should exercise caution. Via InvestorPlace Dow Tumbles 150 Points; Alibaba Earnings Top Views May 18, 2023 U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 150 points on Thursday. The Dow traded down 0.48% to 33,259.03 while the NASDAQ rose 0.63% to 12,579.41. The S&P... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session May 18, 2023 Via Benzinga Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session May 18, 2023 Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility. Via Benzinga Nasdaq Surges 100 Points; Walmart Raises Full-Year Outlook May 18, 2023 U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.09% to 33,451.95 while the NASDAQ rose 0.79% to 12,599.66. The S&P... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 18, 2023 Via Benzinga Enveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of Psilocin May 18, 2023 Enveric Biosciences, Inc. (NASDAQ: ENVB) has received a notice of allowance from the United States Patent and Trademark Office for a patent application involving EB-373, th Via Benzinga Enveric Biosciences Q1 Net Loss Of $4.80M, More On Basic And Diluted Loss Per Share May 15, 2023 Enveric Biosciences, Inc. (NASDAQ: ENVB) released its corporate update and reported financial results for the first quarter of 2023 ending March 31, 2023. Via Benzinga EXCLUSIVE: Fireside With Enveric Biosciences's Dr. Tucker, Unlocking Psychedelic Healing Benefits April 20, 2023 Recently, at the Benzinga Psychedelic Capital Conference, leading experts from the biotech and pharmaceutical industry gathered to discuss the remarkable potential of psychedelics in medicine. Via Benzinga EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key' April 14, 2023 Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental... Via Benzinga What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry April 03, 2023 The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey. Via Benzinga Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More March 27, 2023 Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses Via Benzinga Enveric Creates Subsidiary Down Under To Further Next-Generation Psychedelics Program March 21, 2023 Drug development biotech company Enveric Biosciences (NASDAQ: ENVB) has created Australia-based subsidiary Enveric Therapeutics Pty. Ltd. to support the progress of its next-generation psychedelics... Via Benzinga Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More March 20, 2023 Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered Via Benzinga Enveric Biosciences: Novel Next-Gen Drug Discovery Platform Includes Rare Toad Enzyme March 14, 2023 Biopharma company Enveric Biosciences (NASDAQ: ENVB) has shared new findings involving the first-ever isolation of a specific enzyme from the cane toad, plus the successful development of a... Via Benzinga Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More March 13, 2023 Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial Via Benzinga Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person March 08, 2023 This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established... Via Benzinga Here Are The Year's Highest Priced Psychedelics Stocks In US Markets March 06, 2023 After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on. Via Benzinga The 7 Most Promising Psychedelic Stocks to Buy in February February 05, 2023 These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector. Via InvestorPlace What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways January 03, 2023 What a year for psychedelics! Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session December 21, 2022 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session December 08, 2022 Via Benzinga 15 Global Psychedelics Executives To Keep An Eye On In 2022 October 28, 2022 As the global psychedelics industry booms, with companies going public, major financings being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session September 29, 2022 Gainers Via Benzinga World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them August 30, 2022 The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... Via Benzinga 7 Psychedelics Stocks to Buy for a Big Drug Boom August 30, 2022 These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, GHRS and MNMD can make great investments Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session August 18, 2022 Via Benzinga 7 Short-Squeeze Stocks to Put on Your Must-Watch List August 16, 2022 If you want to zig while the bears zag, these short-squeeze stocks to put on your radar may make for handsome profits. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday August 08, 2022 Pre-market stock movers are the hot topic this morning as we cover all the latest news sending shares higher and lower on Monday! Via InvestorPlace Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday August 05, 2022 Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.